Deferasirox Tablet, Film Coated
Product Images NDC 46708-412

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 46708-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox 180

Deferasirox 180
Each film-coated tablet contains 80mg of deferasirox used for treating chronic iron overload caused by blood transfusions. The usual dosage is not available in this text, but the manufacturer recommends storing at 25°C (77°F) and protecting it from moisture. It is manufactured by Alembic Pharmaceuticals Limited in India and has a National Drug Code (NDC) of 46708-411-30. The medication guide accompanies each package and pharmacists, are expected to dispense it with every order. Children should not have access to the drug, and lot information is not provided.*
FDA Label Image

Deferasirox 360

Deferasirox 360
Each film-coated tablet contains 360 mg of deferasiox. Usual dosage is available in the package insert. Store at a controlled room temperature of 25°C (T7°F) with allowed excursions of 15° to 30°C (59° to 86°F) and protect from moisture. Keep the medicine away from children. The drug is manufactured by Alembic Pharmaceuticals Limited at Village Panelav, P. 0. Tajpura Near Baska, Taluka-Halol, Panchmahal, Gujarat, India. The product is available in the form of tablets with NDC 46708-41_2-30. The medication guide should accompany each patient. This is a prescription drug with a lot number and expiration date.*
FDA Label Image

Deferasirox 90

Deferasirox 90
This is a medication information leaflet for Deferasirox Tablets. The tablets are film-coated and contain 90mg of deferasior. The recommended dosage should be checked on the package insert. The tablets should be stored at room temperature not exceeding 25°C (77°F) and protected from moisture. The manufacturer is Alembic Pharmaceuticals Limited, located in Gujarat, India. The medication should be kept out of reach of children. The lot number for this medication is B0, and the NDC code is 46708-410-30. The pharmacist should provide a medication guide to each patient.*
FDA Label Image

Figure 1 (Deferasirox Figure1)

Figure 1 (Deferasirox Figure1)
This appears to be a table showing the change in liver iron content and serum ferritin levels in response to different doses of deferasirox in a group of patients. There are different sample sizes listed for each dose, and it looks like the data is probably part of a study on iron overload. There is not much context or additional information provided beyond this.*
FDA Label Image

Structure (Deferasirox Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.